Insulin-like growth factor (IGF)-I and IGF-binding activity in normal and fast-growing chickens

Expression and relationship of the insulin-like growth factor system with posthatch growth in the Korean Native Ogol chicken

Insulin-like growth factors (IGF) act as regulators that modulate proliferation and differentiation of various cells. Also, IGF are involved in metabolism and body growth by regulating the synthesis and degradation of glycogen and proteins in animals. However, the effect of IGF system on body growth in poultry including Korean Native Ogol chickens (KNOC) has not been thoroughly studied. Therefore, this study was performed to investigate the expressions of IGF system and the relationship of IGF with body growth during posthatch growth in KNOC. Sera and organs were collected at hatch and at 1, 3, 5, and 7 wk. The mRNA expressions of IGF, IGF-I receptor, and IGF binding protein (IGFBP)-2 were quantitatively analyzed by reverse transcription (RT)-PCR. The IGF concentrations were measured by heterologous RIA, and the expression of IGFBP-2 was detected by Western ligand blotting. The body weight of KNOC rapidly increased during the experimental period, and increase in breast muscle weight was 5-fold from 1 to 3 wk. Although the circulating IGF-I concentration gradually increased, the level of IGF-I in breast muscle rapidly declined during growth period. The IGF-II expression was not similar to IGFBP-2 during postnatal growth. Moreover, the breast muscle IGF-II concentration was mainly correlated with body growth at 7 wk and breast muscle IGF-I at 1 and 5 wk. Taken together, the present study suggested that the endocrine manner of IGF-I was more important than auto/paracrine actions in body growth of KNOC and that expression of IGF-II was involved in body growth and IGF-I during posthatch growth of KNOC.

Evaluation of serum insulin-like growth factor binding proteins (IGFBP) in Angus cattle divergently selected for serum IGF-I concentration

Postweaning serum insulin-like growth factor-I (IGF-I) concentrations and serum IGF binding proteins (IGFBP) were investigated in 68 (1992 Fall-born) and 84 (1999 Fall-born) Angus cattle selected for either high or low serum IGF-I concentrations since 1989. Relative serum levels of IGFBP were determined by [125I]IGF-I Western ligand blotting. IGFBP species of 38-42, 34, 30, and 24 kDa were identified. The 34 kDa species was identified as IGFBP-2 by immunoblot analysis. No significant line effects were observed for any of the IGFBP. In both 1992 and 1999, heifers had higher IGFBP-2 levels than bulls (P<0.0005). In 1992 calves, relative levels of the 38-42 and 24 kDa species were significantly correlated with serum IGF-I concentration. In 1999 calves, none of the IGFBP were correlated with serum IGF-I, although IGFBP-2 was negatively correlated with several measures of body weight. No significant line effects were observed for growth or serum IGF-I traits in 1992 calves. However, 1999 high line calves had higher serum IGF-I concentrations and body weights than low line calves (P<0.05). In both 1992 and 1999 calves, bulls had higher serum IGF-I concentrations and body weights than heifers (P<0.05). Thus, while selection for high versus low serum IGF-I concentrations has resulted in divergence between the selection lines and also in changes in body weights, it has not resulted in changes in serum IGFBP levels. Furthermore, circulating IGFBP-2 appears to be higher in heifers than in bulls, and also appears to be negatively correlated with body weights.

Genetic models for the study of insulin-like growth factors (IGF) and muscle development in birds compared to mammals

IGFs are important positive modulators of overall body and muscle growth in different species. Genetic variation in IGF-I gene expression exists as shown by the possibility of genetic selection for high or low circulating IGF-I concentrations in mice and the associated variations in growth potential. Targeted over-expression of IGF-I in transgenic mice results in muscle hypertrophy, but it is yet unknown whether genetic variability in muscle IGF-I gene expression exists. Much less data are available in birds. This review is focussed on the potential role of IGFs on chicken muscle development. Apart from the absence of a type 2 IGF receptor (IGF-II receptor), the general characteristics of the chicken IGF system seem to be similar to mammalian species. In different genetic models with altered growth rates or body composition, differences in the IGF system are observed suggesting its importance in regulating body growth in those species. The components for a paracrine action of IGF are also present in chicken muscle but it has not yet been demonstrated if they contribute to differences in muscle development.

Insulin-like growth factor (IGF)-I but not IGF-II promotes lean growth and feed efficiency in broiler chickens

The efficacy of exogenous IGFs to stimulate growth and modulate protein and fat deposition was examined in a number of broiler chicken lines. From around 600 g body weight the chickens received a continuous infusion of vehicle (0.1 M acetic acid), human recombinant IGF-I or [Gly1]IGF-II at 300 microg/kg body weight per day, or a combined infusion of 150 microg/kg/day of each IGF for 2 weeks. Experiment 1 used commercial broiler female chickens and included measurements of nitrogen balance, Ntau-methylhistidine excretion and muscle protein synthesis rates. In Experiment 2 the same treatments were applied to three experimental lines of chickens selected for high food consumption (relatively fat), high food utilisation efficiency (relatively lean), or at random (control). IGF-I, but not IGF-II, significantly increased growth rate and food utilisation efficiency by around 10-15% in each experiment, an effect which was consistent across all genotypes. Nitrogen balance was significantly increased by IGF-I in Experiment 1 as was carcass nitrogen content in Experiment 2, indicating that the increased growth was in lean tissue. Carcass fat was consistently reduced in chickens receiving IGF-I and was related to the levels of circulating IGF-I (r2 = 0.30, P < 0.01) but not triiodothyronine. Protein synthesis rates were unaffected by treatment and could not account for increased growth rate. However, there was a significant reduction in Ntau-methylhistidine excretion indicating a reduced rate of muscle protein breakdown in IGF-I-treated chickens (1. 56%/day vs 2.05%/day for IGF-I-treated vs controls, P < 0.05). The efficiency of feed utilisation was inversely related to the rate of protein breakdown (r2 = 0.25, P < 0.01). In conclusion, these experiments are the first to report an enhancement of growth and food utilisation efficiency by broiler chickens receiving exogenous IGF-I. Our results show that IGF-I may be important in controlling the growth and efficiency of food utilisation of young chickens at least in part by modulating the rates of protein breakdown.

Insulin-like growth factors in poultry

A large amount of research, primarily in mammals, has defined to a great extent the pleiotropic effects of the IGF system on growth, development, and intermediary metabolism. Similar elucidations in poultry were hindered to some extent by the absence of native peptides (IGF-I and IGF-II) until their purification, followed by the production of recombinant chicken IGFs. In many ways IGF physiology in birds is similar to that in other species, including but not limited to the fact that IGF-I synthesis is both GH- and GH-independent, and that autocrine-paracrine IGF action is evident. However, it is clear that several unique differences in IGF physiology exist between birds and mammals. For example, more IGF is present in the free form in chickens, and the biological responses to the IGFs is different in several metabolic pathways in birds compared to mammals. To date, no unique IGF-II receptor has been identified in birds. Despite an increasing understanding of the IGFs in aves, several important questions remain to be answered. What is the role of IGF-II in embryo development and posthatch growth? Does an IGF-II receptor entity exist in nonmammalian species? How does nutrition affect IGF-I and IGF-II gene expression, and can this information be used to enhance poultry production? What is the biochemical composition of the IGFBPs, and what are their roles in birds? Can the genetic variation present in poultry be used to positively modify IGF gene expression and physiology? How do the IGFs regulate intermediary metabolism? What is the role of the IGFs in the etiology of several disease states associated with rapid growth in poultry, including tibial dyschondroplasia, obesity, ascites, and spiking mortality syndrome? Answers to these questions are relevant to our understanding of the basic mechanisms of IGF physiology as well as possibly assisting in the amelioration of problems found in modern poultry production.

Developmental changes in serum insulin-like growth factor-I and insulin-like growth factor binding proteins in the turkey embryo

The ontogeny of insulin-like growth factor-I (IGF-I) and ontogeny as well as the molecular nature of the insulin-like growth factor binding proteins (IGFBP) as they relate to embryogenesis and posthatch growth in the turkey have not been reported. In this study, serum samples were harvested from turkey embryos incubated under shell-less and shelled conditions from Day 12 to 28 of incubation. Samples from 3, 6, and 8 wk posthatch were also evaluated. Significant changes in serum IGF-I in shelled embryos were observed in that IGF-I was low in early incubation, peaked at mid-incubation, and returned to levels equivalent to early incubation at hatching. No mid-embryogenesis (Days 14 to 18) increase in serum IGF-I was noted in the shell-less cultures. Embryo weights diverge at Day 18 of incubation, with shell-less embryos being significantly lighter than their age-matched shelled embryos, suggesting a possible relationship between total circulating IGF-I and body weight gain. Three distinct IGFBP were identified in serum from turkey embryos, exhibiting molecular weights of 27, 29, and 69 kDa. During embryonic development, the 29 kDa IGFBP appeared to be the predominant species, with levels peaking on Day 24 of incubation, and being minimally detectable at hatching. Ontogeny of the 29 kDa IGFBP was similar in the shelled and shell-less embryos. The 69-kDa IGFBP-like protein did not appear in the circulation until late in embryogenesis, Day 22 in shell-less and Day 26 in shelled embryos. The 27-kDa IGFBP appeared in late incubation. Similar IGFBP (28, 30, and 69 kDa) were observed in the growing male turkey. The 69-kDa protein did not vary across ages studied, whereas the 28-kDa IGFBP appeared to increase with age. This is the first report describing serum IGF-I and IGFBP in the developing turkey. Turkey IGFBP appear to be regulated by independent events during incubation and posthatch growth.

Circulating IGF-I in plasma of growing male and female turkeys of medium and heavy weight lines

Plasma concentrations of insulin-like growth factor-I (IGF-I) were determined in male and female turkeys from a medium weight (RBC2) and a related heavy weight line (F) from 1 to 28 wks of age. At hatch, the concentrations of IGF-I were relatively low and not different between lines or sexes. During the neonatal period (1 to 7 wks), the concentrations of IGF-I increased and were higher in the faster growing F line and in males. During the juvenile period (8 to 15 wks) the concentrations of IGF-I were higher in males but not different between lines. During the preadolescent period (16 to 21 wks), the concentrations of IGF-I were higher in males but was not different between lines in males while the females of the RBC2 line had higher concentrations than females of the F line. During the adolescent period (22 to 28 wks) the concentrations of IGF-I were higher in males but was not different between lines in males while the females of the RBC2 line had higher concentrations than females of the F line. A phenotypic correlation (+.25) between plasma IGF-I and growth rate was present after statistical absorption of model effects during the neonatal period but not at the later ages. We conclude that IGF-I concentration was positively correlated with growth rate during the neonatal period, but that this relationship changed during the preadolescent and adolescent periods so that IGF-I concentrations were not related to growth rate in males but were negatively related to growth rate in females.

Effect of hypophysectomy on insulin-like growth factor (IGF)-1 binding activity of serum in chickens

1. Hypophysectomy elevated IGF-1 binding activity of serum concurrently with decreases in circulating concentrations of IGF-1 and growth hormone (GH). 2. When sera pooled from each experimental group were chromatographed on a Sephadex G-200 column, IGF-1 binding activity was mainly found in 150 and 30 kilodalton (kDa) proteins. 3. Most of the serum IGF-1 were distributed among 150 kDa protein fractions. 4. Hypophysectomy elevated IGF-1 binding activity of these proteins, especially that of 30 kDa protein. 5. The binding of [125I]IGF-1 to the 30 kDa protein was inhibited by unlabelled IGF-1 but not by insulin, and saturated with a small amount of the ligand compared to the 150 kDa protein. 6. The IGF-1 binding activity of 30 kDa protein was dependent on GH status of chickens.

The effect of increasing photoperiod and food restriction in sexed, broiler-type birds. II. Plasma thyroxine, triiodothyronine, insulin-like growth factor-I and insulin

1. Sexed broiler-type chicks were raised either under a continuous (CON) 23 h light (L) and 1 h dark (D) schedule or an increasing photoperiod (INC). From 5 to 11 d of age birds were fed either: ad libitum (AL), energy intake (kJ ME) restricted to 9.414 x gBW0.67 (R1) or energy intake (kJ ME) restricted to 6.276 x gBW0.67 (R2). 2. Blood samples were taken at 4, 7, 11, 14 d of age and weekly thereafter to 49 d of age. Plasma thyroxine (T4), triiodothyronine (T3), insulin-like growth factor-I (IGF-I) and insulin were determined. 3. CON birds had elevated plasma T3 concentrations to 21 d of age, and greater plasma T4 concentrations at 11 and 21 d of age concurrent with greater food intake. Elevated plasma T3 concentrations in INC birds at 28 d of age coincided with lower plasma IGF-I concentrations at a time when growth and food intake were greater than CON birds. 4. Food restriction elevated plasma insulin and T4 but depressed plasma T3 and IGF-I. Plasma T3 was greater for food-restricted birds at 21 d of age, but subsequently, was generally lower than ad libitum-fed birds which may account for a lack of complete 'catch-up' in growth. 5. Plasma T3 was higher in females at 11 d of age when growth was equivalent for both sexes. From 28 to 42 d, when sex differences in growth became most apparent, plasma T3 was greater in males.

Growth hormone and insulin-like growth factors in poultry growth: required, optimal, or ineffective?

With a continually expanding market for poultry meat products, increased production demands of as much as 50% by the Year 2000 have been predicted. Indications already exist that this magnitude of expansion is not likely to be met by increased production output and genetic selection alone, and that other methods of improving growth performance per bird via exogenous manipulation of the growth process are needed. Studies in mammalian species clearly demonstrate the importance of growth hormone (GH) and its potential for enhancing productivity in domestic mammals. However, the role of GH in growth of poultry appears to be much more complex. Taken collectively, studies to date indicate that significant, positive effects of GH on growth performance of normal, growing poultry are possible. Expression of such effects appear to be largely contingent on the period of posthatch development (late posthatch being more responsive than early), and the pattern of several key metabolic regulatory hormones resulting in response to GH. Such regulatory hormone responses are largely influenced by the pattern or magnitude of exposure (acute versus chronic) to GH in birds. At this time, the available information on the potential for insulin-like growth factors to enhance growth is limited, and further studies are needed before a definitive role for these peptides in growth and development of poultry can be assigned.